Cefpodoxime is indicated for-

• Acute bacterial exacerbation of chronic bronchitis
• Acute community acquired pneumonia
• Pharyngitis or tonsillitis
• Skin and soft tissue infections
• Urinary tract infections
• Uncomplicated gonorrhea
• Acute maxillary sinusitis

Sinusitis	Tonsillitis	Pneumonia	UTI (Urinary Tract Infection)
Skin Infection	Bronchitis	STD (sexually transmitted

Cefpodoxime is available as tablets, capsule, powder for suspension and pediatric drops.

Oral:
Acute otitis media

Child: ≥15 days 4 mg/kg 12 hrly. Max: 200 mg daily.

Oral:
Skin and soft tissue infections

Adult: 200-400 mg 12 hrly.
Child: ≥15 days 4 mg/kg 12 hrly. Max: 200 mg daily.

Oral:
Respiratory tract infections, Urinary tract infections

Adult: 100-200 mg 12 hrly.
Child: ≥15 days 4 mg/kg 12 hrly. Max: 200 mg daily.

Oral:
Uncomplicated gonorrhoea

Adult: 200 mg as a single dose.

How to reconstitute powder for suspension:

Powder For Suspension

How to administer oral drops:

Paediatric Drops

 

Side effects associated with the use of cefpodoxime include-

• gastrointestinal disorders such as-
  • diarrhea
  • nausea
  • vomiting and
  • abdominal pain
• rash, urticaria and itching

Diarrhea

Nausea

Vomiting

Abdominal Pain

• Severe and occasionally deadly hypersensitivity responses have been documented with all beta-lactam antibacterial drugs.
• Antibiotic-associated diarrhea and colitis, including pseudomembranous colitis and Clostridium difficile-associated diarrhea, have been linked to the use of practically all antibiotics, including cefepime, and symptoms can range from mild diarrhea to deadly colitis.

• Cefpodoxime should be used with caution in individuals who are taking powerful diuretics at the same time

• Cefpodoxime, like other antibiotics, can cause non-susceptible organisms to grow out of control.